Grant of Share Options

Summary by AI BETAClose X

Light Science Technologies Holdings plc has announced the surrender and replacement of existing share options held by directors, senior management, and employees with new options. A total of 22,750,275 existing options have been replaced by 27,078,825 new options, all harmonised to an exercise price of 2 pence per ordinary share, aligning with the closing mid-market price on June 3, 2026. This strategic adjustment aims to retain, motivate, and reward key personnel while ensuring their interests are aligned with shareholders, with the company also planning a new long-term incentive plan.

Disclaimer*

Light Science Tech. Holdings PLC
05 June 2026
 

Light Science Technologies Holdings plc

("LSTH", "Light Science", the "Company" or the "Group")

 

Grant of share Options and Surrender of Existing Options

 

Light Science Technologies Holdings plc (AIM: LST), the innovative technology and manufacturing business providing real-world solutions targeting issues including global food security and fire safety, announces that certain existing share options held by directors, senior management and employees have been surrendered and replaced with new share options under the Company's existing share option arrangements.

 

The Board has undertaken a review of the Group's incentive arrangements and concluded that following the recent fundraising, the replacement of certain existing options is appropriate to ensure that the Company's share-based incentive schemes continue to fulfil their intended purpose of retaining, motivating and rewarding key personnel whilst aligning their interests with those of shareholders.

 

Accordingly, options over a total of 22,750,275 ordinary shares ("Existing Options") have been surrendered and replaced with new options over 27,078,825 ordinary shares ("New Options"). The New Options have an exercise price of 2 pence per ordinary share, being the closing mid-market price per ordinary share on 3 June 2026, and retain substantially the same vesting schedules and expiry dates as the Existing Options.

 

The New Options comprise:

·     6,100,000 Existing Options granted on 15 October 2021 with a nil exercise price have been surrendered and replaced by 8,900,000 options with an exercise price of 2p.

·     16,650,275 options granted on 6 March 2024 with an exercise price of 5p have been surrendered and replaced by 18,178,825 options at an exercise price of 2p.

·     All New Options have therefore been harmonised to an exercise price of 2p

 

The Company confirms that, following the grant of the New Options, its share option arrangements remain within the limits approved by shareholders.

 

In addition, the Company intends to establish a new long-term incentive plan (LTIP), based around appropriate performance conditions, which is intended to incentivise long-term performance and sustainable growth.

 

Directors' and PDMR option holdings following grant:

 

Director

Existing Options surrendered

New Options granted and aggregate options held

Simon Deacon

3,330,055

4,858,605

Jim Snooks

4,830,055

5,518,580

Andrew Hempsall

4,830,055

5,518,580

Graham Cooley

6,660,110

6,660,110

Daryl Hollands

700,000

1,021,311

Total

20,350,275

23,577,186

 

 

For additional information please contact:

 

Light Science Technologies Holdings plc

Simon Deacon, Chief Executive Officer

Jim Snooks, Chief Financial Officer

Andrew Hempsall, Chief Operating Officer

 

www.lightsciencetechnologiesholdings.com

via Walbrook PR

 

Shore Capital (Nominated Adviser and Broker)

Stephane Auton / George Payne

 

  +44 (0)20 7408 4050

Walbrook PR Ltd (Media & Investor Relations)

Nick Rome / Marcus Ulker

Tel: +44 (0)20 7933 8780 or lst@walbrookpr.com

 

 

PDMR Notification Forms:

The notification of dealing forms set out below are provided in accordance with the requirements of the UK Market Abuse Regulation.

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

1.     Graham Cooley

2.     Simon Deacon

3.     Jim Snooks

4.     Andrew Hempsall

5.     Daryl Hollands

 

2

Reason for the notification

a)

Position/status

1.     Non-Executive Chair

2.     CEO

3.     CFO

4.     COO

5.     Group Financial Controller

 

b)

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Light Science Technologies Holdings plc

b)

LEI

213800V9MWRRLVQ6EY56

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Surrender and Grant of options under management share option plan

 

Surrender and Grant of options under non-tax advantaged share option plan

Identification code

GB00BNDQJN14

b)

Nature of the transaction

Issue of options over Ordinary Shares

c)

 

Price(s) and volume(s)













Price

Volume(s)







1) 2p exercise price

1) 6,660,110







2) 2p exercise price

2) 4,858,605







3) 2p exercise price

3) 5,518,580







4) 2p exercise price

4) 5,518,580







5) 2p exercise price

5) 1,021,311



d)

 

Aggregated information







- Aggregated volume

N/A - Single transactions





- Price







e)

 

Date of the transaction

4 June 2026

f)

Place of the transaction

Outside a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings